1. Home
  2. Browse
  3. National Institutes of Health
  4. PAR-25-070

PAR-25-070National Institutes of HealthR21

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

Deadline
Award ceiling
Not stated
Awards
Not stated
Posted
Nov 18, 2024

Official announcement on the NIH Guide · opens the funder's page. Always confirm dates there.

Or read the full text and all 3 review criteria here, free with an account. Create free account

Summary

Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for investigator-initiated studies addressing mechanisms by which incretin mimetics, specifically glucagon-like peptide (GLP)-1 or dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP)-1 receptor agonists (RAs), impact…

Related NIH announcements6

Companion announcements with the same title first, then other open R21 announcements on related subjects with at least two weeks to go.

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

PAR-25-069National Institutes of Health3 review criteria on file

—

Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)

PAR-25-044National Institutes of Health3 review criteria on file

—

INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed)

RFA-OD-27-003National Institutes of Health3 review criteria on fileagency framework

$200k

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

PA-25-253National Institutes of Health3 review criteria on fileagency framework

—

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)

PAR-25-346National Institutes of Health3 review criteria on file

—

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

PAR-25-244National Institutes of Health3 review criteria on file

—

The full announcement, free with an account

  • The full announcement text, not just the first two sentences
  • All 3 review criteria reviewers score this against, extracted from this announcement

On Plus, $39 a month

  • The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
  • Funded precedents: what similar NIH projects received, from the award records in NIH RePORTER
  • A Reviewer Scorecard of your draft against these criteria
Create free accountSign in

No card required. Browsing is free.

Subjects

More from National Institutes of Health

Open now with at least two weeks to apply, soonest deadline first.

NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

PAR-25-057National Institutes of Health6 review criteria on file

—

Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)

RFA-DK-27-108National Institutes of Health3 review criteria on fileagency framework

$500k

Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)

RFA-DK-27-139National Institutes of Health

—

Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)

RFA-DK-27-112National Institutes of Health

—

Everything open from National Institutes of Health

Related by subject

Open opportunities sharing the most subjects with this one (Cancer, Metabolic), with at least two weeks to apply.

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

PAR-25-269National Institutes of Health3 review criteria on file

$350k

NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)

PAR-25-271National Institutes of Health3 review criteria on file

—

NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

PAR-25-270National Institutes of Health3 review criteria on file

$1.1M

Everything open tagged Cancer

Hiring in this research area now

All oncology jobs

Source record: https://grants.nih.gov/grants/guide/pa-files/PAR-25-070.htmlVia the NIH Guide. Last checked against the source . Always confirm dates with the funder.